PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438204/2/. Accessed 08 May 2024.
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/2/. Accessed May 8, 2024.
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/2/
PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease [Internet]. In: Cochrane Abstracts. [cited 2024 May 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/2/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
ID - 438204
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/2/
DB - Evidence Central
DP - Unbound Medicine
ER -